Modelling population‐based cancer survival trends by using join point models for grouped survival data

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of the Royal Statistical Society. Series A,

• Publication date

  2009-04-01

• Fields of study

  Mathematics, Medicine

• Identifiers
  DOI 10.1111/j.1467-985X.2009.00580.xPMID 22211005PMCID PMC3247905
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684

  2023cited by this paper
• Improved survival time: What can survival cure models tell us about population‐based survival improvements in late‐stage colorectal, ovarian, and testicular cancer?

  2008cited by this paper
• Inference in segmented line regression: a simulation study

  2008cited by this paper
• Likelihood Ratio Tests for a Change Point with Survival

  2007cited by this paper
• Pancreatic cancer in the general population: Improvements in survival over the last decade

  2006cited by this paper
• Sentinel-node biopsy or nodal observation in melanoma.

  2006cited by this paper
• Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma

  2006cited by this paper
• Estimates of long‐term survival for newly diagnosed cancer patients

  2006cited by this paper
• The University of Rochester model of breast cancer detection and survival.

  2006cited by this paper
• Survival Analysis with Change Point Hazard Functions

  2006cited by this paper
• SEER Cancer Statistics Review, 1975-2003

  2006cited by this paper
• Bayesian model selection for join point regression with application to age‐adjusted cancer rates

  2005cited by this paper
• Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.

  2005influential reference
• Can the Strengths of AIC and BIC Be Shared

  2005cited by this paper
• Cure fraction estimation from the mixture cure models for grouped survival data

  2004cited by this paper
• Multimodel Inference

  2004cited by this paper
• Understanding AIC and BIC in Model Selection

  2004cited by this paper
• EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.

  2003cited by this paper
• Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials.

  2003cited by this paper
• Maximum likelihood estimation of a survival function with a change point for truncated and interval‐censored data

  2002cited by this paper
• A method for constructing complete annual U.S. life tables.

  2000cited by this paper
• Permutation tests for joinpoint regression with applications to cancer rates.

  2000cited by this paper
• Semiparametric Regression Analysis of Interval‐Censored Data

  2000cited by this paper
• A method for constructing complete annual U.S. life tables.

  2000cited by this paper
• Parametric relative survival regression using generalized linear models with application to Hodgkin's lymphoma

  1999cited by this paper
• An investigational new drug treatment program for patients with gemcitabine

  1999cited by this paper
• The changing distribution of stage in nonseminomatous testicular germ cell tumours, from 1977 to 1996

  1999cited by this paper
• Treatment of Locally Advanced Pancreatic Carcinoma in Sweden

  1999cited by this paper
• Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

  1997cited by this paper
• Likelihood ratio tests for a changepoint with survival data

  1997cited by this paper
• Likelihood Ratio Tests for a Change Point with Survival Data

  1997cited by this paper
• Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

  1996cited by this paper
• Consistent Variable Selection in Linear Models

  1995cited by this paper
• Hazard function estimation using B-splines.

  1995cited by this paper
• The impact of breakthrough clinical trials on survival in population based tumor registries.

  1991cited by this paper
• The Cox proportional hazards model with change point: an epidemiologic application.

  1990cited by this paper
• Regression Analysis of Relative Survival Rates

  1987cited by this paper
• The use of mixture models for the analysis of survival data with long-term survivors.

  1982cited by this paper
• Accuracy of cancer death certificates and its effect on cancer mortality statistics.

  1981cited by this paper
• Fitting Segmented Regression Models by Grid Search

  1980cited by this paper
• Estimating the Dimension of a Model

  1978cited by this paper
• Regression analysis of grouped survival data with application to breast cancer data.

  1978cited by this paper
• A review and critique of some models used in competing risk analysis.

  1975cited by this paper
• The Log Likelihood Ratio in Segmented Regression

  1975cited by this paper
• On Asymptotic Distribution Theory in Segmented Regression Problems-- Identified Case

  1975cited by this paper
• Information Theory and an Extension of the Maximum Likelihood Principle

  1973cited by this paper
• Vinblastine in the management of testicular cancer

  1970cited by this paper
• The relative survival rate: a statistical methodology.

  1961cited by this paper

• Trends in childhood cancer: Incidence and survival analysis over 45 years of SEER data

  2025cites this paper
• Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt

  2024cites this paper
• Trends in Cutaneous Melanoma in Nova Scotia With a Focus on 2007 to 2019

  2024cites this paper
• Epidemiology, trends, and survival of ocular and orbital rhabdomyosarcoma: a nationwide study in the USA (1996–2018)

  2024influential citation
• Epidemiologic trends of and factors associated with overall survival in patients with neuroendocrine tumors over the last two decades in the USA

  2023influential citation
• Increase in the Life Expectancy of Cancer Patients in the United States.

  2023cites this paper
• The net effect of wealth on health—Investigating noncommunicable diseases mortality in the context of regional affluence

  2023cites this paper
• Survival Trends Among Adolescents and Young Adults Diagnosed With Cancer in the United States: Comparisons With Children and Older Adults

  2023cites this paper
• Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?

  2022cites this paper
• Changing presidential approval: Detecting and understanding change points in interval censored polling data

  2022cites this paper
• Time trends of major cancers incidence and mortality in Guangzhou, China 2004–2015: A Joinpoint and Age–Period–Cohort Analysis

  2021cites this paper
• Characterizing Trends in Cancer Patients' Survival Using the JPSurv Software

  2021cites this paper
• TRENDS IN PREMATURE MORTALITY RATES AMONG THE POLISH POPULATION DUE TO CARDIOVASCULAR DISEASES

  2021cites this paper
• Premature Mortality Due to Tobacco-Related Malignancies in Poland

  2021cites this paper
• Premature Mortality Due to Chronic Obstructive Pulmonary Disease (COPD) in Poland

  2021cites this paper
• Tendencias de mortalidad por VIH/SIDA en la ciudad de Pereira, Colombia (2002-2014): estudio ecológico

  2020cites this paper
• The utility of joinpoint regression for estimating population parameters given changes in population structure

  2019cites this paper
• Time-varying Readmission Diagnoses During 30 Days After Hospitalization for COPD Exacerbation

  2018cites this paper
• Increasing complexity of cancer care : how displaced treatments impact efficiency, cost-effectiveness and equity

  2018cites this paper
• Hepatitis C virus‐related complications are increasing in women veterans: A national cohort study

  2017cites this paper
• MicroRNA-26a inhibits the growth and invasiveness of malignant melanoma and directly targets on MITF gene

  2017cites this paper
• MicroRNA-15a inhibits the growth and invasiveness of malignant melanoma and directly targets on CDCA4 gene

  2016cites this paper
• Contributions of HIV to Non-Hodgkin Lymphoma Mortality Trends in the United States

  2016cites this paper
• When do changes in cancer survival mean progress? The insight from population incidence and mortality.

  2014cites this paper
• Cancer survival: an overview of measures, uses, and interpretation.

  2014cites this paper
• ANALYSIS OF INCIDENCE AND MORTALITY TRENDS 2 . 1 Joinpoint modeling – is the trend changing ?

  2014cites this paper
• Signal transducers and activators of transcription 3 function in lung cancer.

  2013cites this paper
• Predicting county‐level cancer incidence rates and counts in the USA

  2013cites this paper
• Histological and Demographic Characteristics of the Distribution of Brain and Central Nervous System Tumors’ Sizes: Results from SEER Registries Using Statistical Methods

  2012cites this paper
• Artificial Mixture Methods for Correlated Nominal Responses and Discrete Failure Time

  2012cites this paper
• Statistical analysis and modeling: cancer, clinical trials, environment and epidemiology.

  2011cites this paper
• Forecasting mortality in the event of a structural change

  2011cites this paper
• Index of authors, volume 172, 2009

  2009cites this paper